Mertz Philippe

#Rheumatology and #Immunology resident

[CRMR RESO | PACIFIC @CRMR_RESO]

Check the latest paper 📚 from @CRMR_RESO with @MertzP @PrTmartin_RESO & @Lupusreference ➡️ #Infliximab is an effective #glucocorticoid-sparing #treatment for #Takayasu arteritis: Results of a multicenter open-label prospective study
https://t.co/FsjahoW0fv

[Laurent ARNAUD @Lupusreference]

👍 My take on the current management of #lupus #nephritis (mix of the latest @eular_org & @goKDIGO recommendations). Please RT & comment🙏. I would definitely appreciate some feedback 🔄 from #nephrology colleagues as it was a tough job to assemble this slide!! 🏥
#SLE #renal

[Laurent ARNAUD @Lupusreference]

Check this #paper 📄 from our national reference center for auto-immune diseases 🏥 (@CRMR_RESO with @MertzP & @PrTmartin_RESO) about the clinical spectrum and #treatment management 💊 of #autoimmune #myelofibrosis. Most patients had systemic #lupus 🐺
https://t.co/wKI5MPaBZn

[Laurent ARNAUD @Lupusreference]

The HISTORY of #lupus 🤓
Check my new video about how, why and when the term "lupus" 🐺 appeared and discover its complex history, overlapping with that of tuberculosis and syphilis until the concepts of cutaneous lupus #CLE and #SLE were well defined.
➡️https://t.co/eMfhGEcm9L

[CRMR RESO | PACIFIC @CRMR_RESO]

🚨 Check the latest paper 📃 from @CRMR_RESO about #world-wide 🌍🌎🌏 mortality of 6 #autoimmune #diseases 🏥: #lupus, #scleroderma, #Sjogren, #myositis, #MCTD and #vasculitis and discover the data 📈 for your own country! 🗺️
Final version at: https://t.co/1U4rzE9jWW

[CRMR RESO | PACIFIC @CRMR_RESO]

🚨 Check the latest paper 📑 of @Lupusreference with @m_scherlinger & @Professeur_geek.
Discover the major #inequities in the #mortality of #autoimmune diseases in the #world 🌍🌎🌏
Link: https://t.co/1U4rzEqVlw
#lupus #scleroderma #sjogren #MCTD #Vasculitis #myositis

[Mike Putman @EBRheum]

Raoult PRE-print: 79 pts w/COVID improve, also receive HCQ

1. Not peer rvwd
2. No control group
3. Incl pts from prior study
4. Migratory/weak endpts
5. Healthy group: 41% only URI & 5% asymptomatic!?!

Not confirmatory; not progress. Need. RCTs.

PDF: https://t.co/Mbrq7bFHk0

[Laurent ARNAUD @Lupusreference]

With #coronavirus most meetings are canceled but we can still share knowledge using #twitter 👍.
🆕 Here is my lecture 🗣️
on #interferons & #lupus #SLE planned for #BBI2020. Link to pdf (46Mo): https://t.co/EcFq6c5Rln
Please leave me a comment 📖 (or RT) if you download it! 🤳

[NEJM @NEJM]

Among patients with severe antineutrophil cytoplasmic antibody–associated vasculitis, plasma exchange did not reduce the incidence of death or end-stage kidney disease.

[Renaud Felten @DocFelten]

Read our latest #article on #Psout, combining psoriasis/PsA and gout, published with in @ClinRheumatol 🥰
>> https://t.co/bvdV3LvZUu

[American College of Rheumatology @ACRheum]

Vasculitis & Ulcerative Colitis Overlap: How rare is this condition, and how do we diagnose it? https://t.co/IgFNciS0lj

[Mike Putman @EBRheum]

PEXIVAS fact-RCT, PLEX v PLBO & ⬆️ or ⬇️ steroid (60% less) taper in AAV w/renal or pulm dx, @NEJM

Re:death/ESRD: no benefit to PLEX (28% vs 31%, NS and NNT ~38)

Reduced taper noninferior to standard (HR ~ 1) & fewer infxns! (27% vs 33%, NNT ~17)

Less PLEX; less steroid

[Nicølªs Kluger 🇫🇷🇫🇮 @NicoKluger]

Syndrome papulo-purpurique en gants🧤et chaussettes 🧦
1️⃣Parvovirus B19
2️⃣Rougeole
3️⃣Rubeole
4️⃣HBV
5️⃣HIV
6️⃣HHV6
7️⃣HHV7
8️⃣CMV, EBV, Cocsackie
9️⃣ Bactéries
🔟 Médicaments
📕Source: Saurat JH. Dermatologie et IST

[NEJM @NEJM]

Image Challenge: A 53-year-old man presented to the ED with a 1-month history of relapsing fevers, dyspnea, and rapidly progressive skin lesions. What is the most likely diagnosis? https://t.co/kQrNuVExlQ

[American College of Rheumatology @ACRheum]

The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease https://t.co/s0TWa8CVHZ

[MaRIH @Filiere_MaRIH]

[Nouvelle classification des #déficits #immunitaires #héréditaires] 📣

Retrouvez la nouvelle classification des #DIH (n= 416) mise à jour par le Comité d'experts de l'Union internationale des sociétés d'immunologie 👨‍🏫

▶️ https://t.co/wgjX2fjLUB

[Isabelle Meyts @IsabelleMeyts]

Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys Mutation (outside the C-terminal domain). Tribute to a unique patient. Thank you ⁦⁦@stutangye⁩ lab. Thanks to all! https://t.co/4hMjkL6l6U

[CRMR RESO | PACIFIC @CRMR_RESO]

SAVE THE DATE
La 3ème édition de la #WINTERSCHOOL des maladies #autoimmunes et inflammatoires du #RESO STRASBOURG se déroulera les 26 et 27 novembre 2020!

[NEJM @NEJM]

NEJM Case Challenge: A 44-year-old man was evaluated because of diarrhea and progressive weight loss, plus an episode of culture-negative meningitis. What is the most likely diagnosis? #casechallenge #NEJMCases https://t.co/KcKSgMovIA